Benzinga - by Lisa Levin, Benzinga Editor.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
- Keybanc raised monday.com Ltd. (NASDAQ: MNDY) price target from $180 to $185. Keybanc analyst Jason Celino maintained an Overweight rating. monday.com shares rose 10.5% to close at $154.83 on Monday. See how other analysts view this stock.
- Raymond James cut the price target for Passage Bio, Inc. (NASDAQ: PASG) from $9 to $5. Raymond James analyst Danielle Brill maintained an Outperform rating. Passage Bio shares closed at $0.60 on Monday. See how other analysts view this stock.
- Telsey Advisory Group boosted Abercrombie & Fitch Co. (NYSE: ANF) price target from $62 to $74. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. Abercrombie & Fitch shares fell 0.9% to close at $66.39 on Monday. See how other analysts view this stock.
- Bernstein cut the price target for The J. M. Smucker Company (NYSE: SJM) from $123 to $119. Bernstein analyst Alexia Howard upgraded the stock from Underperform to Market Perform. Smucker shares fell 0.5% to close at $108.20 on Monday. See how other analysts view this stock.
- Barclays increased the price target for The Mosaic Company (NYSE: MOS) from $40 to $42. Barclays analyst Benjamin Theurer upgraded the stock from Underweight to Overweight. Mosaic shares gained 2.6% to close at $34.50 on Monday. See how other analysts view this stock.
- Baird raised Aspen Technology, Inc. (NASDAQ: AZPN) price target from $194 to $202. Baird analyst Rob Oliver upgraded the stock from Neutral to Outperform. Aspen Technology shares rose 1.7% to $169.15 in pre-market trading. See how other analysts view this stock.
- Piper Sandler cut Cara Therapeutics, Inc. (NASDAQ: CARA) price target from $12 to $1. Piper Sandler analyst David Amsellem downgraded the stock from Overweight to Neutral. Cara Therapeutics shares fell 0.9% to $1.17 in pre-market trading. See how other analysts view this stock.
- Canaccord Genuity slashed the price target for The Beauty Health Company (NASDAQ: SKIN) from $10 to $2.5. Canaccord Genuity analyst Susan Anderson downgraded the stock from Buy to Hold. Beauty Health shares fell 49% to $1.99 in pre-market trading. See how other analysts view this stock.
- TD Cowen cut Surgery Partners, Inc. (NASDAQ: SGRY) price target from $39 to $35. TD Cowen analyst Gary Taylor upgraded the stock from Market Perform to Outperform. Surgery Partners shares gained 3.2% to $27.55 in pre-market trading. See how other analysts view this stock.
- HC Wainwright & Co. cut BioNTech SE (NASDAQ: BNTX) price target from $180 to $133. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. BioNTech shares rose 0.2% to $98.09 in pre-market trading. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Check This Out: Top 4 Risk Off Stocks You'll Regret Missing In Q4
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.